In this regard, they share similar risk factors in terms of comorbidities as advanced age (87), and diabetes (90), although they have specific peculiarities as hypertension and biological therapy with CD20 inhibitors for COVID-19 and HIV infection, malnourishment and biological therapy based on TNF-α inhibitors for TB (90) (Table 1). Here, TNF is linked to tuberculosis.